Abstract:Objective:To study the curative efficacy of naloxone combined with edaravone in the treatment of severe cerebral infarction and its effects on the plasma tumor necrosis factor(TNF)-α and interleukin(IL)-6 levels.Methods:92 patients of severe cerebral infarction who were treated from October 2014 to October 2016 in our hospital were selected.According to random number table,those patients were divided into the observation group (n=46) and the control group (n=46).Both groups were given lipid-lowering therapy,blood glucose control,blood pressure,intracranial pressure,maintenance of water electrolyte,brain cells and other conventional treatment.The control group was treated with intravenous infusion of edaravone,a dose of 30 mg,2 times/d,while the observation group was combined with intravenous infusion of naloxone,a dose of 2 mg,1 times/d,they were continuously treated for 14 days.The clinical curative effect and the changes of plasma TNF-α,IL-6 levels,NIHSS score and Barthel index before and after treatment and the incidence of adverse reactions were compared between two groups.Results:At 14d after treatment,the total effective rate of observation group was significantly higher than that of the control group (P＜0.05).Compared with before treatment,the plasma TNF-α,IL-6 levels and NIHSS score of both groups were significantly decreased after treatment between the two groups (P＜0.05),while the Barthel index was significantly incresed (P＜0.05).The plasma TNF-α and IL-6 levels and NIHSS score of observation group were significantly lower than those of the control group(P＜0.05),and the Barthel index was significantly higher than that of the control group(P＜0.05).There were no serious adverse reactions in the two groups.Conclusion:Naloxone combined with edaravone was effective for severe cerebral infarction,which could effectively reduce plasma levels ofTNF-α,IL-6,promote the recovery of neurological function with high security.

Curative Efficacy of Naloxone Combined with Edaravone in the Treatment of Severe Cerebral Infarction and Its Effects on the Plasma TNF-α and IL-6 Levels